Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chas G Newstead

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 4, 2003
Recurrent disease in renal transplantsChas G Newstead
Transplantation|January 26, 2010
The clinical significance of early proteinuria after renal transplantationAravind Cherukuri, Matthew P Welberry-Smith, James E Tattersall, et al.
Transplantation|March 19, 2008
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantationMatthew P Welberry Smith, Chas G Newstead, Niaz Ahmad, et al.
Transplantation|September 24, 2013
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trialMatthew P Welberry Smith, Aravind Cherukuri, Chas G Newstead, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 4, 2003
Recurrent disease in renal transplantsChas G Newstead
Transplantation|January 26, 2010
The clinical significance of early proteinuria after renal transplantationAravind Cherukuri, Matthew P Welberry-Smith, James E Tattersall, et al.
Transplantation|March 19, 2008
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantationMatthew P Welberry Smith, Chas G Newstead, Niaz Ahmad, et al.
Transplantation|September 24, 2013
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trialMatthew P Welberry Smith, Aravind Cherukuri, Chas G Newstead, et al.
Pageof 1